海洋生物製剤の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR3559)
◆英語タイトル:Global Marine Biopharmaceutical Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3559
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:127
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、海洋生物製剤の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(医薬品、健康補助食品)、用途別市場規模(病院・クリニック、薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・海洋生物製剤の市場動向
・企業の競争状況、市場シェア
・海洋生物製剤の種類別市場規模(医薬品、健康補助食品)
・海洋生物製剤の用途別市場規模(病院・クリニック、薬局、その他)
・海洋生物製剤の北米市場規模2016-2027(アメリカ、カナダ)
・海洋生物製剤の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・海洋生物製剤のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・海洋生物製剤の中南米市場規模2016-2027(メキシコ、ブラジル)
・海洋生物製剤の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Seattle Genetics、DSM、Eisai Co、Takeda、BASF、Amway、Pfizer、Pelagia (EPAX)、Pharma Mar SA、Croda、GNC、GSK、TerSera Therapeutics、Nordic Naturals、Carlson Labs)
・結論
【レポートの概要】

Market Analysis and Insights: Global Marine Biopharmaceutical Market
The global Marine Biopharmaceutical market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Marine Biopharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Marine Biopharmaceutical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Marine Biopharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Marine Biopharmaceutical market.

Global Marine Biopharmaceutical Scope and Market Size
Marine Biopharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Marine Biopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Health Supplement

Segment by Application
Hospital & Clinic
Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Takeda
BASF
GSK
TerSera Therapeutics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Health Supplement
1.3 Market by Application
1.3.1 Global Marine Biopharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Marine Biopharmaceutical Market Perspective (2016-2027)
2.2 Marine Biopharmaceutical Growth Trends by Regions
2.2.1 Marine Biopharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Marine Biopharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Marine Biopharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Marine Biopharmaceutical Industry Dynamic
2.3.1 Marine Biopharmaceutical Market Trends
2.3.2 Marine Biopharmaceutical Market Drivers
2.3.3 Marine Biopharmaceutical Market Challenges
2.3.4 Marine Biopharmaceutical Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Marine Biopharmaceutical Players by Revenue
3.1.1 Global Top Marine Biopharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Marine Biopharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Marine Biopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Marine Biopharmaceutical Revenue
3.4 Global Marine Biopharmaceutical Market Concentration Ratio
3.4.1 Global Marine Biopharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marine Biopharmaceutical Revenue in 2020
3.5 Marine Biopharmaceutical Key Players Head office and Area Served
3.6 Key Players Marine Biopharmaceutical Product Solution and Service
3.7 Date of Enter into Marine Biopharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Marine Biopharmaceutical Breakdown Data by Type
4.1 Global Marine Biopharmaceutical Historic Market Size by Type (2016-2021)
4.2 Global Marine Biopharmaceutical Forecasted Market Size by Type (2022-2027)

5 Marine Biopharmaceutical Breakdown Data by Application
5.1 Global Marine Biopharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Marine Biopharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Marine Biopharmaceutical Market Size (2016-2027)
6.2 North America Marine Biopharmaceutical Market Size by Type
6.2.1 North America Marine Biopharmaceutical Market Size by Type (2016-2021)
6.2.2 North America Marine Biopharmaceutical Market Size by Type (2022-2027)
6.2.3 North America Marine Biopharmaceutical Market Size by Type (2016-2027)
6.3 North America Marine Biopharmaceutical Market Size by Application
6.3.1 North America Marine Biopharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Marine Biopharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Marine Biopharmaceutical Market Size by Application (2016-2027)
6.4 North America Marine Biopharmaceutical Market Size by Country
6.4.1 North America Marine Biopharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Marine Biopharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Marine Biopharmaceutical Market Size (2016-2027)
7.2 Europe Marine Biopharmaceutical Market Size by Type
7.2.1 Europe Marine Biopharmaceutical Market Size by Type (2016-2021)
7.2.2 Europe Marine Biopharmaceutical Market Size by Type (2022-2027)
7.2.3 Europe Marine Biopharmaceutical Market Size by Type (2016-2027)
7.3 Europe Marine Biopharmaceutical Market Size by Application
7.3.1 Europe Marine Biopharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Marine Biopharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Marine Biopharmaceutical Market Size by Application (2016-2027)
7.4 Europe Marine Biopharmaceutical Market Size by Country
7.4.1 Europe Marine Biopharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Marine Biopharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Marine Biopharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Marine Biopharmaceutical Market Size by Type
8.2.1 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Marine Biopharmaceutical Market Size by Type (2016-2027)
8.3 Asia-Pacific Marine Biopharmaceutical Market Size by Application
8.3.1 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Marine Biopharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Marine Biopharmaceutical Market Size by Region
8.4.1 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Marine Biopharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Marine Biopharmaceutical Market Size (2016-2027)
9.2 Latin America Marine Biopharmaceutical Market Size by Type
9.2.1 Latin America Marine Biopharmaceutical Market Size by Type (2016-2021)
9.2.2 Latin America Marine Biopharmaceutical Market Size by Type (2022-2027)
9.2.3 Latin America Marine Biopharmaceutical Market Size by Type (2016-2027)
9.3 Latin America Marine Biopharmaceutical Market Size by Application
9.3.1 Latin America Marine Biopharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Marine Biopharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Marine Biopharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Marine Biopharmaceutical Market Size by Country
9.4.1 Latin America Marine Biopharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Marine Biopharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Marine Biopharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Marine Biopharmaceutical Market Size by Type
10.2.1 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Marine Biopharmaceutical Market Size by Type (2016-2027)
10.3 Middle East & Africa Marine Biopharmaceutical Market Size by Application
10.3.1 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Marine Biopharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Marine Biopharmaceutical Market Size by Country
10.4.1 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Marine Biopharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Seattle Genetics
11.1.1 Seattle Genetics Company Details
11.1.2 Seattle Genetics Business Overview
11.1.3 Seattle Genetics Marine Biopharmaceutical Introduction
11.1.4 Seattle Genetics Revenue in Marine Biopharmaceutical Business (2016-2021)
11.1.5 Seattle Genetics Recent Development
11.2 DSM
11.2.1 DSM Company Details
11.2.2 DSM Business Overview
11.2.3 DSM Marine Biopharmaceutical Introduction
11.2.4 DSM Revenue in Marine Biopharmaceutical Business (2016-2021)
11.2.5 DSM Recent Development
11.3 Eisai Co
11.3.1 Eisai Co Company Details
11.3.2 Eisai Co Business Overview
11.3.3 Eisai Co Marine Biopharmaceutical Introduction
11.3.4 Eisai Co Revenue in Marine Biopharmaceutical Business (2016-2021)
11.3.5 Eisai Co Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Marine Biopharmaceutical Introduction
11.4.4 Takeda Revenue in Marine Biopharmaceutical Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 BASF
11.5.1 BASF Company Details
11.5.2 BASF Business Overview
11.5.3 BASF Marine Biopharmaceutical Introduction
11.5.4 BASF Revenue in Marine Biopharmaceutical Business (2016-2021)
11.5.5 BASF Recent Development
11.6 Amway
11.6.1 Amway Company Details
11.6.2 Amway Business Overview
11.6.3 Amway Marine Biopharmaceutical Introduction
11.6.4 Amway Revenue in Marine Biopharmaceutical Business (2016-2021)
11.6.5 Amway Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Marine Biopharmaceutical Introduction
11.7.4 Pfizer Revenue in Marine Biopharmaceutical Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Pelagia (EPAX)
11.8.1 Pelagia (EPAX) Company Details
11.8.2 Pelagia (EPAX) Business Overview
11.8.3 Pelagia (EPAX) Marine Biopharmaceutical Introduction
11.8.4 Pelagia (EPAX) Revenue in Marine Biopharmaceutical Business (2016-2021)
11.8.5 Pelagia (EPAX) Recent Development
11.9 Pharma Mar SA
11.9.1 Pharma Mar SA Company Details
11.9.2 Pharma Mar SA Business Overview
11.9.3 Pharma Mar SA Marine Biopharmaceutical Introduction
11.9.4 Pharma Mar SA Revenue in Marine Biopharmaceutical Business (2016-2021)
11.9.5 Pharma Mar SA Recent Development
11.10 Croda
11.10.1 Croda Company Details
11.10.2 Croda Business Overview
11.10.3 Croda Marine Biopharmaceutical Introduction
11.10.4 Croda Revenue in Marine Biopharmaceutical Business (2016-2021)
11.10.5 Croda Recent Development
11.11 GNC
11.11.1 GNC Company Details
11.11.2 GNC Business Overview
11.11.3 GNC Marine Biopharmaceutical Introduction
11.11.4 GNC Revenue in Marine Biopharmaceutical Business (2016-2021)
11.11.5 GNC Recent Development
11.12 GSK
11.12.1 GSK Company Details
11.12.2 GSK Business Overview
11.12.3 GSK Marine Biopharmaceutical Introduction
11.12.4 GSK Revenue in Marine Biopharmaceutical Business (2016-2021)
11.12.5 GSK Recent Development
11.13 TerSera Therapeutics
11.13.1 TerSera Therapeutics Company Details
11.13.2 TerSera Therapeutics Business Overview
11.13.3 TerSera Therapeutics Marine Biopharmaceutical Introduction
11.13.4 TerSera Therapeutics Revenue in Marine Biopharmaceutical Business (2016-2021)
11.13.5 TerSera Therapeutics Recent Development
11.14 Nordic Naturals
11.14.1 Nordic Naturals Company Details
11.14.2 Nordic Naturals Business Overview
11.14.3 Nordic Naturals Marine Biopharmaceutical Introduction
11.14.4 Nordic Naturals Revenue in Marine Biopharmaceutical Business (2016-2021)
11.14.5 Nordic Naturals Recent Development
11.15 Carlson Labs
11.15.1 Carlson Labs Company Details
11.15.2 Carlson Labs Business Overview
11.15.3 Carlson Labs Marine Biopharmaceutical Introduction
11.15.4 Carlson Labs Revenue in Marine Biopharmaceutical Business (2016-2021)
11.15.5 Carlson Labs Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 海洋生物製剤の世界市場規模・現状・予測2021年-2027年(Global Marine Biopharmaceutical Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。